These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2931441)

  • 1. Insulin receptor capping and its correlation with calmodulin-dependent myosin light chain kinase.
    Majercik MH; Bourguignon LY
    J Cell Physiol; 1985 Sep; 124(3):403-10. PubMed ID: 2931441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced myosin light-chain phosphorylation during receptor capping in IM-9 human B-lymphoblasts.
    Majercik MH; Bourguignon LY
    Biochem J; 1988 Jun; 252(3):815-23. PubMed ID: 3048249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte activation and capping of hormone receptors.
    Bourguignon LY; Jy W; Majercik MH; Bourguignon GJ
    J Cell Biochem; 1988 Jun; 37(2):131-50. PubMed ID: 3135294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of myosin light chain kinase with lymphocyte membrane-cytoskeleton complex.
    Bourguignon LY; Nagpal ML; Balazovich K; Guerriero V; Means AR
    J Cell Biol; 1982 Dec; 95(3):793-7. PubMed ID: 6984047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium control of actin-myosin based contraction in triton models of mouse 3T3 fibroblasts is mediated by the myosin light chain kinase (MLCK)-calmodulin complex.
    Holzapfel G; Wehland J; Weber K
    Exp Cell Res; 1983 Oct; 148(1):117-26. PubMed ID: 6605252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-calmodulin-dependent myosin phosphorylation by pancreatic islets.
    MacDonald MJ; Kowluru A
    Diabetes; 1982 Jun; 31(6 Pt 1):566-70. PubMed ID: 6295860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca2+-calmodulin-dependent myosin light chain kinase is essential for activation of TRPC5 channels expressed in HEK293 cells.
    Shimizu S; Yoshida T; Wakamori M; Ishii M; Okada T; Takahashi M; Seto M; Sakurada K; Kiuchi Y; Mori Y
    J Physiol; 2006 Jan; 570(Pt 2):219-35. PubMed ID: 16284075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calmodulin antagonists inhibit activity of myosin light-chain kinase independent of calmodulin.
    Zimmer M; Hofmann F
    Eur J Biochem; 1984 Jul; 142(2):393-7. PubMed ID: 6547673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of receptor capping in mouse lymphoma T cells by Ca2+-activated myosin light chain kinase.
    Kerrick WG; Bourguignon LY
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):165-9. PubMed ID: 6582474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory Ca(2+)-regulation of myosin light chain kinase in the lower eukaryote, Physarum polycephalum: role of a Ca(2+)-dependent inhibitory factor.
    Okagaki T; Ishikawa R; Kohama K
    Eur J Cell Biol; 1991 Oct; 56(1):113-22. PubMed ID: 1666040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+--Calmodulin dependent myosin light-chain phosphorylating activity in insulin-secreting tissues.
    Penn EJ; Brocklehurst KW; Sopwith AM; Hales CN; Hutton JC
    FEBS Lett; 1982 Mar; 139(1):4-8. PubMed ID: 6281063
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse.
    Isotani E; Zhi G; Lau KS; Huang J; Mizuno Y; Persechini A; Geguchadze R; Kamm KE; Stull JT
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6279-84. PubMed ID: 15071183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Yamakado T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphorylation in the pancreatic B-cell.
    Harrison DE; Ashcroft SJ; Christie MR; Lord JM
    Experientia; 1984 Oct; 40(10):1075-84. PubMed ID: 6208050
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
    Nakajima T; Katoh A
    Mol Pharmacol; 1987 Jul; 32(1):140-6. PubMed ID: 3037298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of an epitope-tagged calmodulin useful for the analysis of calmodulin-binding proteins: addition of a hemagglutinin epitope does not affect calmodulin-dependent activation of smooth muscle myosin light chain kinase.
    Szymanska G; O'Connor MB; O'Connor CM
    Anal Biochem; 1997 Oct; 252(1):96-105. PubMed ID: 9324946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calmodulin-myosin light chain kinase inhibition changes fibroblast-populated collagen lattice contraction, cell migration, focal adhesion formation, and wound contraction.
    Levinson H; Moyer KE; Saggers GC; Ehrlich HP
    Wound Repair Regen; 2004; 12(5):505-11. PubMed ID: 15453832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors.
    Stout MA; Silver PJ
    J Cell Physiol; 1992 Oct; 153(1):169-75. PubMed ID: 1522130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of calmodulin binding to purified human lymphocyte plasma membranes.
    Lee TP; Venuti J; Macara I; Kawauchi R; Davis PJ; Mookerjee BK
    J Immunol; 1987 Jul; 139(1):42-8. PubMed ID: 3584987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.